NCT06901791View on ClinicalTrials.gov

Efficacy of Lactobacillus Rhamnosus LRa05 in Gestational Diabetes

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 10, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

March 10, 2026

Conditions
GDM
Interventions
DIETARY_SUPPLEMENT

Conventional treatment and Probiotic

Participants will continuously take Lactobacillus rhamnosus LRa05 from the time of enrollment until delivery.

Trial Locations (1)

Unknown

RECRUITING

Suzhou Municipal Hospital, Suzhou

All Listed Sponsors
lead

Wecare Probiotics Co., Ltd.

INDUSTRY